01 / 05
Repligen Launches TangenX® SC as First-to-Market Holder-Free Self-Contained TFF Device
Repligen Corporation yoday announced the commercial launch of TangenX® SC, the industry’s first holder-free, self-contained Tangential Flow Filtration (TFF) device.The technology is especially suited to the manufacture of biologics where fully closed systems are critical or ideal.
Repligen completes the acquisition of Metenova
Repligen acquired Metenova, a leading Swedish innovator in magnetic mixing technology for biopharmaceutical production. This strategic step further strengthens Repligen's Fluid Management franchise, enriching our single-use mixing solutions and expanding our product range. Welcome, Metenova!
Repligen acquires FlexBiosys Inc.
Repligen today entered an agreement to acquire FlexBiosys Inc. of Branchburg, NJ. The acquisition is another step in building out Repligen’s Fluid Management franchise, adding a full range of single-use bioprocessing bags and assemblies to our product offering. The addition of FlexBiosys complements and vertically integrates our systems offering, providing a more complete single-use fluid management portfolio of products for our biopharmaceutical manufacturing customers. Welcome FlexBiosys!
Introducing the KrosFlo® KR2i RPM™ System
Monitor concentration during your UF/DF run with the new KrosFlo KR2i RPM System. Featuring in-line protein concentration management, you control your process with the power of the KrosFlo KR2i TFF System and insights from the CTech™ FlowVPX® System.
Expanding Process Analytics: Daylight Solutions
Repligen will assume responsibility for the commercialization of Culpeo®, as well as the development of future products and technologies in the fast-growing Process Analytics Technology (PAT) segment of the bioprocessing market.